AlfaKinetic
by Anervea
LandscapeMonitorCompareProfileAsk
principle

Nothing is shown without a source. When the data can’t answer, the product says so.

LB Pharmaceuticals
tenant
drug

Digital Medicine System

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Otsuka Pharmaceutical Development & Commercialization, Inc.
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Investigational (via trials)
SchizophreniaFirst Episode PsychosisSchizophreniaPsychotic DisordersSchizoaffective Disorder

Trials

1
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
NCT03568500Phase 4Completed

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Otsuka Pharmaceutical Development & Commercialization, Inc.
company
trial
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
PHASE4
trial
indication
Schizophrenia
indication
First Episode Psychosis
indication
Schizophrenia
indication
Psychotic Disorders
indication